Hydrocortisone for Secondary Prevention of Post-Traumatic Stress Disorder: A Case Report.

Mil MedSep 1, 2026
Case ReportPsychiatry

Victoria H Harrison, Paimon Ameli, Gregory S Zhang

✦ AI-curated · Sources linked

Case in brief

An Active-Duty Marine experienced a traumatic event during an emergency medical technician shift, leading to a diagnosis of Acute Stress Reaction. He was treated with a 10-day course of oral hydrocortisone followed by a taper. The patient showed significant symptomatic improvement, returned to work without limitations, and did not develop PTSD.

Diagnostic / clinical pearl

Hydrocortisone may be beneficial as a secondary prevention strategy for PTSD in select cases following acute stress reactions.

Why it matters

This case underscores the potential role of glucocorticoids in mitigating PTSD symptoms, particularly in military personnel, highlighting the need for further research in this area.

Source

PubMed · PMID 42693942

Published in Mil Med. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Psychiatry

Clinical ResearchOncology (Medical)

Osimertinib With or Without Chemotherapy in Advanced Non-Small Cell Lung Cancer With EGFR and Concurrent TP53 Mutations: A Randomized Clinical Trial.

This phase 3 randomized clinical trial evaluated the efficacy and safety of osimertinib combined with chemotherapy versus osimertinib alone in 294 patients with advanced non-small cell lung cancer (NSCLC) harboring…

JAMASep 8, 2026Open accessRead summary
Clinical ResearchHematology

Azacitidine-Venetoclax or Induction Chemotherapy for Acute Myeloid Leukemia.

This phase 2 randomized trial compared azacitidine plus venetoclax to induction chemotherapy in 172 previously untreated adults with acute myeloid leukemia (AML) eligible for induction.

N Engl J MedSep 3, 2026Read summary
Clinical ResearchPsychiatry

The efficacy of modified psychodynamic psychotherapy for patients with schizophrenia-spectrum disorders in Germany: a prospective, single-centre, assessor-blinded, parallel-group, randomised controlled trial.

This randomized controlled trial evaluated the efficacy of Modified Psychodynamic Psychotherapy for Schizophrenia (MPP-S) combined with treatment as usual (TAU) in 130 outpatients with schizophrenia-spectrum disorders…

Lancet PsychiatrySep 10, 2026Read summary

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text
Create my personalized digestSee plans

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.